Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...

Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...

A Biograph study using AI on routine heart CT scans found inflammation that cholesterol tests and risk calculators could not ...

The Boston company says the deal more than doubles its patient reach and opens a path to brain-based sleep testing in primary care from 2027.

United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.

Fitnescity Health opens its 1,000-plus imaging locations to digital health platforms through one API, with Superpower on ...

Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

Organoids are full of cells that shouldn’t be there, and sorting them out wrecks the vasculature. SynBITE prunes in place instead.

XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

After 12 weeks, members of Omada’s GLP-1 Care Track had lost more weight and shifted their body makeup more than people on usual care. A bathroom scale gives you one number and keeps everything else ...

Bio says its Activin E antibody kept weight loss closer to pure fat in monkeys on semaglutide, and could one day be dosed twice a year.